Essentially, the study suggests that an FMD can reprogram pancreatic cells to renew insulin production in type 1 diabetes patients’ islets and mitigate symptoms of both type 1 and type 2 diabetes in mice (4). Here, INS is linked to type 2 diabetes mellitus.